PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Diabetes vaccine gives promising results in a genetic subgroup

Diabetes vaccine gives promising results in a genetic subgroup
2021-05-24
(Press-News.org) A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body's own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.

In type 1 diabetes, the body's immune system attacks the cells that produce insulin. When the insulin-producing cells have disappeared, the body can no longer regulate blood sugar level, and a person with type 1 diabetes must take exogenous insulin for the rest of his or her life.

A highly topical question in research into type 1 diabetes is whether, and if so how, the attack of the immune system can be slowed or even completely stopped. One possible strategy is based on altering the immune defence by injecting a protein that the cells of the immune system react to, in a form of vaccination. One of the proteins against which the immune system often forms antibodies in type 1 diabetes is known as GAD65 (glutamic acid decarboxylase). Professor Johnny Ludvigsson at Linköping University has studied for many years the possibility of vaccinating people who have newly diagnosed type 1 diabetes with GAD. It is hoped that the immune system will become more tolerant against the body's own GAD, and stop damaging the insulin-producing cells, such that the body can continue to form some insulin.

"Studies have shown that even an extremely small production of insulin in the body is highly beneficial for patient health. People with diabetes who produce a certain amount of insulin naturally do not develop low blood sugar levels, hypoglycaemia, so easily. They have also a lower risk of developing the life-threatening condition ketoacidosis, which can arise when the insulin level is low", says Johnny Ludvigsson, senior professor in the Department of Biomedical and Clinical Sciences at Linköping University.

Johnny Ludvigsson has led DIAGNODE-2, a clinical phase 2 study in which researchers investigated the effect of GAD-alum (Diamyd) injections into the lymph nodes of 109 young people with recently diagnosed type 1 diabetes. The natural insulin production of the participants was measured at the start of the study and again after 15 months. Several other outcome measures were also followed, such as change in long-term blood sugar levels (HbA1c), and how much supplementary insulin the patients needed to take every day.

Previous studies of immunotherapy in diabetes have suggested that genetic factors play a role in how patients respond to the treatment. This led the researchers in DIAGNODE-2 to look at several variants of what are known as "HLA genes". These genes code for proteins located on the surface of some cells. They function as holders of proteins, and expose them to immune system cells passing by. If the protein fragment exposed in this way comes from, for example, bacteria, the immune system should form antibodies against the foreign protein. However, the immune system sometimes reacts against the body's own substances, and certain types of HLA are associated with an increased risk of type 1 diabetes. The HLA variant HLA-DR3-DQ2 exposes the GAD65 protein to cells of the immune system, and patients with this variant often form antibodies against GAD65 at an early stage of the disease. Around half of the participants in the study had the HLA-DR3-DQ2 variant.

For the complete patient group, there was no difference between treatment and placebo in the degree to which insulin production was preserved. GAD-alum did, however, have a positive effect for the subgroup of patients who had the DR3-DQ2 variant of HLA genes.

"The patients in the subgroup with the DR3-DQ2 type of HLA genes did not lose insulin production as quickly as the other patients. In contrast, we did not see any significant effect in the patients who did not have this HLA type", says Johnny Ludvigsson.

No undesired effects that could be related to treatment with GAD-alum were seen during the study.

"Treatment with GAD-alum seems to be a promising, simple and safe way to preserve insulin production in around half of patients with type 1 diabetes, the ones who have the right type of HLA. This is why we are looking forward to carrying out larger studies, and we hope these will lead to a drug that can change the progress of type 1 diabetes", says Johnny Ludvigsson.

The study has been financed by Diamyd Medical AB, the Swedish Child Diabetes Foundation, and the Swedish Diabetes Foundation. The pharmaceutical company Diamyd Medical was involved in planning and the collection of data. One of the authors, Ulf Hannelius, is employed by Diamyd Medical.

The study: The 109 participants, aged between 12 and 24 years, had been diagnosed with type 1 diabetes within the preceding 6 months, and were allocated at random to one of two groups. One group received three injections of GAD-alum at intervals of 1 month and vitamin D in tablet form, while the other group (controls) received placebo. Neither the participants nor the researchers knew which patients received treatment with GAD-alum (the study was randomised and double-blind).

The article: "Intralymphatic glutamic acid decarboxylase with Vitamin D supplementation in recent onset Type 1 diabetes: a double-blind randomized placebo-controlled Phase IIb trial", Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A Martínez-Brocca, MariSol Ruiz de Adana, Jeanette Wahlberg, Anastasia Katsarou, Ragnar Hanas, Cristina Hernandez, Maria Clemente León, Ana Gómez-Gila, Marcus Lind, Marta Ferrer Lozano, Theo Sas, Ulf Samuelsson, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Anders Nordlund, Ulf Hannelius and Rosaura Casas, (2021), Diabetes Care, published online on May 21 2021, doi: 10.2337/dc21-0318

INFORMATION:


[Attachments] See images for this press release:
Diabetes vaccine gives promising results in a genetic subgroup

ELSE PRESS RELEASES FROM THIS DATE:

Clean water and toilets for healthy shelters

Clean water and toilets for healthy shelters
2021-05-24
Regular, standardized assessments of evacuation shelters can help keep people healthy following natural disasters, according to research published by Tohoku University scientists and colleagues in the journal Heliyon. The study found that a clean tap water supply and hygienic toilets were especially important for protecting evacuees from the spread of infectious diseases. "A clean water supply and maintaining hygiene are important for reducing environmental health risks among victims of natural disasters," says Tadashi Ishii, who specializes in disaster medicine at Tohoku University. "But scientists have not yet established a strong evidence base that describes the relationship between damage in resource supplies and infrastructure ...

Pristine quantum criticality found

Pristine quantum criticality found
2021-05-24
HOUSTON - (May 24, 2021) - U.S. and Austrian physicists searching for evidence of quantum criticality in topological materials have found one of the most pristine examples yet observed. In an open access paper published online in Science Advances, researchers from Rice University, Johns Hopkins University, the Vienna University of Technology (TU Wien) and the National Institute of Standards and Technology (NIST) present the first experimental evidence to suggest that quantum criticality -- a disordered state in which electrons waver between competing states of order -- may give rise to topological phases, "protected" quantum states that are of growing interest ...

Deep and extreme: Microbes thrive in transition

Deep and extreme: Microbes thrive in transition
2021-05-24
A diverse microbial community has adapted to an extremely salty environment deep in the Red Sea. The microbes, many unknown to science, occupy a one-meter-thick area overlying the Suakin Deep, an expansive 80-meter-deep brine lake, 2,771 meters below the central Red Sea. The chemical properties of this thin "brine-seawater interface," along with the composition of microbial communities, change surprisingly rapidly across a sharp gradient. "Our study sheds light on how microorganisms in the Suakin Deep's brine-seawater interface make an oasis of life in the desert of the deep Red Sea," says microbial ...

Keeping it rolling

Keeping it rolling
2021-05-24
Osaka, Japan - Scientists from the Institute of Scientific and Industrial Research, and NTN Next Generation Research Alliance Laboratories at Osaka University developed a machine learning method that combines convolutional neural networks and Bayesian hierarchical modeling to precisely predict the remaining useful life of rolling bearings. This work may lead to new industrial monitoring methods that help manage maintenance schedules and maximize efficiency and safety under defect progression. A rolling bearing consists of two rings separated by rolling elements (balls or rollers). Because of the ease of rolling, the rings can rotate relative to each other with very little friction. Rolling bearings are essential to almost all automated machinery with rotating elements. The bearings ...

To make particles flow more efficiently, put an obstacle in their way

2021-05-24
Scientists used to perform experiments by stirring biological and chemical agents into test tubes. Nowadays, they automate research by using microfluidic chips the size of postage stamps. In these tiny devices, millions of microscopic particles are captured in droplets of water, each droplet serving as the "test tube" for a single experiment. The chip funnels these many droplets, one at a time, through a tiny channel where a laser probes each passing droplet to record thousands of experimental results each second. These chips are used for such things as testing new antibiotics, screening drug compounds, sequencing the DNA and RNA of single cells, and otherwise speeding up the pace of scientific ...

36 dwarf galaxies had simultaneous 'baby boom' of new stars

36 dwarf galaxies had simultaneous baby boom of new stars
2021-05-24
Three dozen dwarf galaxies far from each other had a simultaneous "baby boom" of new stars, an unexpected discovery that challenges current theories on how galaxies grow and may enhance our understanding of the universe. Galaxies more than 1 million light-years apart should have completely independent lives in terms of when they give birth to new stars. But galaxies separated by up to 13 million light-years slowed down and then simultaneously accelerated their birth rate of stars, according to a Rutgers-led study published in the Astrophysical Journal. "It appears that these galaxies are responding to a large-scale ...

The birth of a subnanometer-sized soccer ball

2021-05-24
Ever since the existence of molecules was proven and molecular reactions were predicted, humans have wanted to visually observe how such events proceed. Such observations of single-molecule reactions are highly important for the fundamental understanding of chemical sciences, which would aid in the development of novel catalysts, materials, or drugs, and help us decipher the complex biochemical processes. However, this was not possible for the longest time in modern chemistry, and so far the information of dynamical processes on the nanometer scale was obtained only from indirect methods because molecules ...

Digital Twin technology a 'powerful tool' but requires significant investment, say experts

2021-05-24
Healthcare and aerospace experts at King's College London, The Alan Turing Institute, the University of Cambridge, and the Oden Institute for Computational Engineering and Sciences at UT Austin in Texas have said advances in digital twin technology make it a powerful tool for facilitating predictive and precision medicine and enhancing decision-making for aerospace systems. Their opinion piece was published today in Nature Computational Science. When applied to healthcare, the digital twin, a virtual version of real-life objects that can be used to predict how that object will perform, could predict how a patient's disease will develop and how patients are likely to respond to different therapies. It is also of huge benefit in aerospace, where, for example, the technology ...

Pre-Columbus climate change may have caused Amazon population decline

2021-05-24
Climate change impacts felt in the Amazon rainforest prior to the arrival of European settlers after 1492 may have meant populations of indigenous people were already in decline before the 'Great Dying', new research has suggested. Scientists studying fossil pollen and charcoal data from across the Amazon say it appears to show that human management of the rainforest may have peaked around 1200 AD, before some sites were abandoned, allowing reforestation of these areas. The new research, involving University of Reading scientists and published in the journal Science, challenges the prior assumption that the largest population decrease in the Americas - known as the Great Dying - did not start until after European settlers carried new diseases to ...

Generating electricity from heat using the spin Seebeck device

Generating electricity from heat using the spin Seebeck device
2021-05-24
Thermoelectric (TE) conversion offers a carbon-free power generation from geothermal, waste, body or solar heat, and shows promise to be the next-generation energy conversion technology. At the core of such TE conversion, there lies an all solid-state thermoelectric device which enables energy conversion without the emission of noise, vibrations, or pollutants. To this, a POSTECH research team proposed a way to design the next-generation thermoelectric device that exhibits remarkably simple manufacturing process and structure compared to the conventional ones, while displaying ...

LAST 30 PRESS RELEASES:

NASA’s Parker Solar Probe makes history with closest pass to Sun

Are we ready for the ethical challenges of AI and robots?

Nanotechnology: Light enables an "impossibile" molecular fit

Estimated vaccine effectiveness for pediatric patients with severe influenza

Changes to the US preventive services task force screening guidelines and incidence of breast cancer

Urgent action needed to protect the Parma wallaby

Societal inequality linked to reduced brain health in aging and dementia

Singles differ in personality traits and life satisfaction compared to partnered people

President Biden signs bipartisan HEARTS Act into law

Advanced DNA storage: Cheng Zhang and Long Qian’s team introduce epi-bit method in Nature

New hope for male infertility: PKU researchers discover key mechanism in Klinefelter syndrome

Room-temperature non-volatile optical manipulation of polar order in a charge density wave

Coupled decline in ocean pH and carbonate saturation during the Palaeocene–Eocene Thermal Maximum

Unlocking the Future of Superconductors in non-van-der Waals 2D Polymers

Starlight to sight: Breakthrough in short-wave infrared detection

Land use changes and China’s carbon sequestration potential

PKU scientists reveals phenological divergence between plants and animals under climate change

Aerobic exercise and weight loss in adults

Persistent short sleep duration from pregnancy to 2 to 7 years after delivery and metabolic health

Kidney function decline after COVID-19 infection

Investigation uncovers poor quality of dental coverage under Medicare Advantage

Cooking sulfur-containing vegetables can promote the formation of trans-fatty acids

How do monkeys recognize snakes so fast?

Revolutionizing stent surgery for cardiovascular diseases with laser patterning technology

Fish-friendly dentistry: New method makes oral research non-lethal

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

[Press-News.org] Diabetes vaccine gives promising results in a genetic subgroup